Annual EBITDA
-$4.52 M
+$2.18 M+32.51%
01 December 2023
Summary:
Xenetic Biosciences annual earnings before interest, taxes, depreciation & amortization is currently -$4.52 million, with the most recent change of +$2.18 million (+32.51%) on 01 December 2023. During the last 3 years, it has risen by +$150.00 thousand (+3.21%). XBIO annual EBITDA is now -11877.98% below its all-time high of -$37.70 thousand, reached on 01 August 2013.XBIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$499.50 K
+$837.90 K+62.65%
01 September 2024
Summary:
Xenetic Biosciences quarterly earnings before interest, taxes, depreciation & amortization is currently -$499.50 thousand, with the most recent change of +$837.90 thousand (+62.65%) on 01 September 2024. Over the past year, it has increased by +$647.20 thousand (+56.44%). XBIO quarterly EBITDA is now -111.26% below its all-time high of $4.44 million, reached on 31 December 2017.XBIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$4.36 M
+$647.20 K+12.92%
01 September 2024
Summary:
Xenetic Biosciences TTM earnings before interest, taxes, depreciation & amortization is currently -$4.36 million, with the most recent change of +$647.20 thousand (+12.92%) on 01 September 2024. Over the past year, it has increased by +$462.40 thousand (+9.59%). XBIO TTM EBITDA is now -38492.92% below its all-time high of -$11.30 thousand, reached on 30 November 2011.XBIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XBIO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.5% | +56.4% | +9.6% |
| 3 y3 years | +3.2% | +63.5% | +13.8% |
| 5 y5 years | +37.8% | +91.2% | +56.3% |
XBIO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +32.5% | at high | +81.3% | at high | +42.0% |
| 5 y | 5 years | at high | +52.8% | at high | +91.2% | at high | +56.3% |
| alltime | all time | <-9999.0% | +91.5% | -111.3% | +99.0% | <-9999.0% | +92.7% |
Xenetic Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$499.50 K(-62.7%) | -$4.36 M(-12.9%) |
| June 2024 | - | -$1.34 M(+5.4%) | -$5.01 M(+2.9%) |
| Mar 2024 | - | -$1.27 M(+1.0%) | -$4.87 M(+7.8%) |
| Dec 2023 | -$4.52 M(-32.5%) | -$1.26 M(+9.5%) | -$4.52 M(-6.4%) |
| Sept 2023 | - | -$1.15 M(-4.3%) | -$4.82 M(+6.8%) |
| June 2023 | - | -$1.20 M(+30.9%) | -$4.52 M(-24.7%) |
| Mar 2023 | - | -$915.20 K(-41.5%) | -$6.00 M(-10.4%) |
| Dec 2022 | -$6.69 M(+17.2%) | -$1.56 M(+86.2%) | -$6.69 M(-4.3%) |
| Sept 2022 | - | -$839.80 K(-68.6%) | -$6.99 M(-7.0%) |
| June 2022 | - | -$2.68 M(+66.3%) | -$7.52 M(+26.1%) |
| Mar 2022 | - | -$1.61 M(-13.6%) | -$5.96 M(+4.4%) |
| Dec 2021 | -$5.71 M(+22.4%) | -$1.86 M(+36.4%) | -$5.71 M(+12.9%) |
| Sept 2021 | - | -$1.37 M(+22.2%) | -$5.06 M(+2.3%) |
| June 2021 | - | -$1.12 M(-17.8%) | -$4.95 M(+3.0%) |
| Mar 2021 | - | -$1.36 M(+12.3%) | -$4.80 M(+2.9%) |
| Dec 2020 | -$4.67 M(-51.3%) | -$1.21 M(-3.4%) | -$4.67 M(-0.3%) |
| Sept 2020 | - | -$1.25 M(+28.7%) | -$4.68 M(-48.5%) |
| June 2020 | - | -$975.40 K(-20.3%) | -$9.08 M(-4.1%) |
| Mar 2020 | - | -$1.22 M(-0.3%) | -$9.47 M(-1.1%) |
| Dec 2019 | -$9.58 M(+31.9%) | -$1.23 M(-78.3%) | -$9.58 M(-4.1%) |
| Sept 2019 | - | -$5.66 M(+313.7%) | -$9.98 M(+62.5%) |
| June 2019 | - | -$1.37 M(+3.1%) | -$6.14 M(-9.2%) |
| Mar 2019 | - | -$1.33 M(-19.0%) | -$6.76 M(-6.8%) |
| Dec 2018 | -$7.26 M(+104.8%) | -$1.64 M(-9.8%) | -$7.26 M(+510.7%) |
| Sept 2018 | - | -$1.81 M(-8.8%) | -$1.19 M(-26.2%) |
| June 2018 | - | -$1.99 M(+9.1%) | -$1.61 M(-36.1%) |
| Mar 2018 | - | -$1.82 M(-141.1%) | -$2.52 M(-28.9%) |
| Dec 2017 | -$3.54 M | $4.44 M(-298.4%) | -$3.54 M(-57.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$2.24 M(-22.8%) | -$8.32 M(+1.4%) |
| June 2017 | - | -$2.90 M(+1.7%) | -$8.21 M(-84.5%) |
| Mar 2017 | - | -$2.85 M(+731.0%) | -$52.97 M(-0.9%) |
| Dec 2016 | -$53.44 M(+338.6%) | -$342.70 K(-83.8%) | -$53.44 M(-5.5%) |
| Sept 2016 | - | -$2.12 M(-95.5%) | -$56.58 M(-5.1%) |
| June 2016 | - | -$47.66 M(+1336.7%) | -$59.65 M(+354.9%) |
| Mar 2016 | - | -$3.32 M(-4.7%) | -$13.11 M(+8.7%) |
| Dec 2015 | -$12.18 M(-14.3%) | -$3.48 M(-32.9%) | -$12.06 M(-6.1%) |
| Sept 2015 | - | -$5.19 M(+361.6%) | -$12.85 M(+18.8%) |
| June 2015 | - | -$1.12 M(-50.4%) | -$10.82 M(-13.0%) |
| Mar 2015 | - | -$2.27 M(-46.9%) | -$12.43 M(-12.5%) |
| Dec 2014 | -$14.21 M(+66.7%) | -$4.27 M(+35.3%) | -$14.21 M(+42.1%) |
| Sept 2014 | - | -$3.16 M(+15.3%) | -$10.00 M(+45.1%) |
| June 2014 | - | -$2.74 M(-32.3%) | -$6.89 M(+65.7%) |
| Mar 2014 | - | -$4.05 M(+6816.6%) | -$4.16 M(+4512.0%) |
| Dec 2013 | -$8.53 M(>+9900.0%) | - | - |
| Nov 2013 | - | -$58.50 K(+16.3%) | -$90.20 K(+139.3%) |
| Aug 2013 | - | -$50.30 K(+906.0%) | -$37.70 K(+69.8%) |
| Aug 2013 | -$37.70 K(-99.4%) | - | - |
| May 2013 | - | -$5000.00(-121.2%) | -$22.20 K(-53.3%) |
| Feb 2013 | - | $23.60 K(-493.3%) | -$47.50 K(-48.3%) |
| Dec 2012 | -$6.17 M(+6249.8%) | - | - |
| Nov 2012 | - | -$6000.00(-82.8%) | -$91.90 K(-5.5%) |
| Aug 2012 | - | -$34.80 K(+14.9%) | -$97.20 K(+55.8%) |
| Aug 2012 | -$97.20 K | - | - |
| May 2012 | - | -$30.30 K(+45.7%) | -$62.40 K(+94.4%) |
| Feb 2012 | - | -$20.80 K(+84.1%) | -$32.10 K(+184.1%) |
| Nov 2011 | - | -$11.30 K | -$11.30 K |
FAQ
- What is Xenetic Biosciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Xenetic Biosciences?
- What is Xenetic Biosciences annual EBITDA year-on-year change?
- What is Xenetic Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Xenetic Biosciences?
- What is Xenetic Biosciences quarterly EBITDA year-on-year change?
- What is Xenetic Biosciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Xenetic Biosciences?
- What is Xenetic Biosciences TTM EBITDA year-on-year change?
What is Xenetic Biosciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of XBIO is -$4.52 M
What is the all time high annual EBITDA for Xenetic Biosciences?
Xenetic Biosciences all-time high annual earnings before interest, taxes, depreciation & amortization is -$37.70 K
What is Xenetic Biosciences annual EBITDA year-on-year change?
Over the past year, XBIO annual earnings before interest, taxes, depreciation & amortization has changed by +$2.18 M (+32.51%)
What is Xenetic Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of XBIO is -$499.50 K
What is the all time high quarterly EBITDA for Xenetic Biosciences?
Xenetic Biosciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $4.44 M
What is Xenetic Biosciences quarterly EBITDA year-on-year change?
Over the past year, XBIO quarterly earnings before interest, taxes, depreciation & amortization has changed by +$647.20 K (+56.44%)
What is Xenetic Biosciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of XBIO is -$4.36 M
What is the all time high TTM EBITDA for Xenetic Biosciences?
Xenetic Biosciences all-time high TTM earnings before interest, taxes, depreciation & amortization is -$11.30 K
What is Xenetic Biosciences TTM EBITDA year-on-year change?
Over the past year, XBIO TTM earnings before interest, taxes, depreciation & amortization has changed by +$462.40 K (+9.59%)